adverse effects of glp 1 GI Glucagon-Like Peptide-1 Receptor Agonists The current significance and prospects
Description
Addiction in a New Form

J Alzheimers Dis (2010) 19(4):120519

In a head-to-head comparison of semaglutide and tirzepatide published earlier this month, tirzepatide was found more likely to lead to significant weight loss

Participants were instructed to eat, smoke, or inhale each active or placebo compound within 10 min, while they were not required to finish the dose

(Source: Dual Therapeutic Benefits of Glycemic Control and Weight Management In contrast to many conventional therapies, GLP-1 analogues decrease appetite and encourage weight loss in addition to controlling blood sugar levels
Depending on your state, this may require a video consultation
